What format should be used for nucleotide sequences in patent applications?

What format should be used for nucleotide sequences in patent applications?

According to MPEP 2412.05, nucleotide sequences in patent applications must follow a specific format:

“A nucleotide sequence must be presented as a lowercase sequence using the standard symbols for nucleotides.”

This means that when presenting nucleotide sequences in your patent application:

• Use lowercase letters
• Employ standard symbols for nucleotides (a, c, g, t for DNA; a, c, g, u for RNA)
• Do not use any other characters or formatting that could interfere with the clarity of the sequence

Adhering to this format ensures consistency across patent applications and facilitates accurate interpretation of the genetic information by patent examiners and other readers.

To learn more:

• nucleotide sequences
• patent applications
• sequence format
• standard symbols